Cytokinetics Announces Initiation of Phase 1 Clinical Study of AMG 594, a Cardiac Troponin Activator

NEXT STORY
Global $30 Billion Human Immunodeficiency Virus (HIV) Drugs Market 2019-2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts
PREV STORY
Mustang Bio and Nationwide Children’s Hospital Enter into Exclusive Worldwide License Agreement for Oncolytic Virus (C134) to Treat Glioblastoma Multiforme
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Lumos Pharma to Host Key Opinion Leader Event on LUM-201 for the Treatment of Pediatric Growth Hormone Deficiency

author_avatar
NASDAQ Market News

Global Medical Imaging Software Market Forecast to 2024 – Siemens Healthcare, Philips Healthcare, GE Healthcare, and IBM Corporation are Dominating

author_avatar
NASDAQ Market News

FIT Biotech Oy: FIT Biotech Oy’s Board of Directors has decided on the directed share issue without payment to the Company itself

FIT Biotech OyCompany release November 30, 2017 at 4 pm FIT Biotech Oy's Board ...

author_avatar
NASDAQ Market News